PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
06-Jan-2022 Nimbus Therapeutics Announces Expansion of Oral Allosteric TYK2 Inhibitor Program and Provides Additional Business Updates Businesswire
06-Jan-2022 Anokion Announces Progress Across Pipeline of Novel Autoimmune Programs Businesswire
06-Jan-2022 Charles River Laboratories to Present at J.P. Morgan Healthcare Conference Businesswire
06-Jan-2022 Ambagon Therapeutics Launches With $85 Million Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline Businesswire
06-Jan-2022 Iveric Bio Announces the Addition of Global Pharmaceutical Veteran, Christine Ann Miller, to its Board of Directors Businesswire
06-Jan-2022 Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Development and Technical Operations Capability Businesswire
06-Jan-2022 RayzeBio to Present at J.P. Morgan Healthcare Virtual Conference on Tuesday, January 11, 2022 Businesswire
06-Jan-2022 Rallybio Highlights Portfolio Advances and Outlines Expected Upcoming Milestones for 2022 Businesswire
06-Jan-2022 InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright BioConnect Conference Businesswire
06-Jan-2022 Axcella Therapeutics Details Clinical and Operational Milestones for 2022 Businesswire
06-Jan-2022 Alnylam Announces Collaboration with Novartis to Explore Targeted Therapy to Restore Liver Function Businesswire
06-Jan-2022 Apnimed to Present at the 40th Annual JP Morgan Healthcare Conference Businesswire
06-Jan-2022 BeiGene to Present at the J.P. Morgan 40th Annual Healthcare Conference Businesswire
06-Jan-2022 Nextech AR Sees Strong 3D Model Demand From Large Manufacturers Showcasing Its CAD To Poly 3D/AR Technology Businesswire
06-Jan-2022 Global Synthetic Biology (Enzymes, Cloning Technologies Kits) Market Report 2021-2027 - Opportunities in the Development of Vaccines and Personalized Medicines & Demand for Biofuel - ResearchAndMarkets.com Businesswire
06-Jan-2022 AngioDynamics Reports Fiscal 2022 Second Quarter Financial Results; Reaffirms Revenue Guidance; Revises Gross Margin and Adjusted EPS Guidance Businesswire
06-Jan-2022 Pillar Biosciences Receives CLIA Certification for its Next-Generation Sequencing Clinical Laboratory Businesswire
06-Jan-2022 Allay Therapeutics Establishes Corporate Headquarters in the Bay Area and Expands Base of Operations in Singapore Businesswire
06-Jan-2022 FDA Grants Breakthrough Device Designation to JelikaLite Businesswire
06-Jan-2022 Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and Outlook for 2022 at the 40th Annual J.P. Morgan Healthcare Conference Businesswire